BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
PRODID://AAFS//454411
BEGIN:VEVENT
DTSTAMP:20260403T214358
VTIMEZONE:America/New_York
DTSTART:20251124T180000Z
DTEND:20251124T190000Z
UID:454411
SUMMARY:CAAMS Seminar: Strategies to potentiate clinically used antimicrobials to overcome biofilm-related antimicrobial resistance
LOCATION:
DESCRIPTION:CAAMS Seminar: Strategies to potentiate clinically used antimicrobials to overcome biofilm-related antimicrobial resistance\n\n11/24/25 01:00 PM EST\n - 11/24/25 02:00 PM EST\Description:\nJoin us for our monthly CAAMS Seminar Series presented by experts in their field.\n \n\nNovember 24, 2025; 1:00 - 2:00 pm Eastern\n\n \n\nStrategies to potentiate clinically used antimicrobials to overcome biofilm-related antimicrobial resistance\n\nAntimicrobial resistance poses a critical threat to both human and animal health, often driven by the ability of pathogens to form biofilms and evade treatment. This seminar will highlight innovative strategies to enhance the efficacy of existing antimicrobial drugs.\n\nPresented by: Priyank Kumar, BPharm, MS, PhD\n\nDr. Priyank Kumar is an Associate Professor of pharmacology at Western University. The Priyank Lab investigates critical molecular mechanisms underlying microbial pathogenicity and drug resistance, particularly in contexts where veterinary and human patients face environmental toxins and substances of abuse. Our research employs innovative approaches to understand how these external factors influence microbial behavior and drug response profiles. Our primary focus is deciphering the complex interactions between microorganisms and host systems under stressed conditions. We examine how exposure to environmental toxins and substances of abuse alters microbial virulence factors and antimicrobial resistance patterns. By characterizing how different microbes respond to various stressors and antimicrobial agents, we aim to optimize treatment protocols that consider both the pathogen's characteristics and the patient's exposure history. Our goal is to advance the field of precision antimicrobial therapy by understanding the fundamental relationships between environmental factors, microbial adaptation, and treatment efficacy. \n\n \n\n \n\n \n\n \n
X-ALT-DESC;FMTTYPE=text/html:CAAMS Seminar: Strategies to potentiate clinically used antimicrobials to overcome biofilm-related antimicrobial resistance<br /><br />11/24/25 01:00 PM EST - 11/24/25 02:00 PM EST<br />Description:<br /><p>Join us for our monthly CAAMS Seminar Series presented by experts in their field.<br />
&nbsp;</p>

<p><strong>November 24, 2025; 1:00 - 2:00 pm Eastern</strong></p>

<p>&nbsp;</p>

<p><strong>Strategies to potentiate clinically used antimicrobials to overcome biofilm-related antimicrobial resistance</strong></p>

<p>Antimicrobial resistance poses a critical threat to both human and animal health, often driven by the ability of pathogens to form biofilms and evade treatment. This seminar will highlight innovative strategies to enhance the efficacy of existing antimicrobial drugs.</p>

<p><strong>Presented by:&nbsp;Priyank Kumar, BPharm, MS, PhD</strong></p>

<p>Dr. Priyank Kumar is an Associate Professor of pharmacology at Western University. The Priyank Lab investigates critical molecular mechanisms underlying microbial pathogenicity and drug resistance, particularly in contexts where veterinary and human patients face environmental toxins and substances of abuse. Our research employs innovative approaches to understand how these external factors influence microbial behavior and drug response profiles. Our primary focus is deciphering the complex interactions between microorganisms and host systems under stressed conditions. We examine how exposure to environmental toxins and substances of abuse alters microbial virulence factors and antimicrobial resistance patterns. By characterizing how different microbes respond to various stressors and antimicrobial agents, we aim to optimize treatment protocols that consider both the pathogen's characteristics and the patient's exposure history. Our goal is to advance the field of precision antimicrobial therapy by understanding the fundamental relationships between environmental factors, microbial adaptation, and treatment efficacy.&nbsp;</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<form action="https://portal.iscaid.org/i4a/ams/meetings/index.cfm?controller=meetings&amp;action=goToRegistration" method="post">&nbsp;</form>

PRIORITY:3
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-PT5M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR